Compare LOVE & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LOVE | RPID |
|---|---|---|
| Founded | 1998 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 227.3M | 204.3M |
| IPO Year | 2018 | 2021 |
| Metric | LOVE | RPID |
|---|---|---|
| Price | $14.57 | $1.71 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $25.00 | $8.00 |
| AVG Volume (30 Days) | ★ 170.5K | 123.4K |
| Earning Date | 06-11-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 2.78 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $697,115,000.00 | $33,587,000.00 |
| Revenue This Year | $4.63 | $19.12 |
| Revenue Next Year | $6.40 | $18.42 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 2.42 | ★ 19.74 |
| 52 Week Low | $10.33 | $1.66 |
| 52 Week High | $20.88 | $4.94 |
| Indicator | LOVE | RPID |
|---|---|---|
| Relative Strength Index (RSI) | 39.66 | 31.20 |
| Support Level | $14.43 | N/A |
| Resistance Level | $15.59 | $2.46 |
| Average True Range (ATR) | 0.89 | 0.12 |
| MACD | -0.22 | -0.01 |
| Stochastic Oscillator | 18.56 | 9.80 |
The Lovesac Co designs, manufactures and sells alternative furniture which is comprised of modular couches called sactionals and premium foam beanbag chairs called sacs. It also offers other accessories such as sactional-specific drink holders, Footsac blankets, decorative pillows, fitted seat tables, and ottomans. Its products are sold across the United States through its website or company-owned retail stores which are used in homes and offices. The majority of the firm's revenue is derived from the sale of Sactionals.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.